| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.85e-05 | 4 | 63 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | cullin family protein binding | 7.39e-05 | 26 | 63 | 3 | GO:0097602 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.26e-04 | 31 | 63 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.46e-04 | 6 | 63 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.98e-04 | 36 | 63 | 3 | GO:0031624 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 3.15e-04 | 42 | 63 | 3 | GO:0044390 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 7.16e-04 | 128 | 63 | 4 | GO:0032182 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.37e-04 | 129 | 63 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 8.27e-04 | 133 | 63 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.00e-03 | 140 | 63 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.23e-03 | 254 | 63 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.32e-03 | 151 | 63 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.45e-03 | 18 | 63 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | amino acid binding | 1.59e-03 | 73 | 63 | 3 | GO:0016597 | |
| GeneOntologyBiologicalProcess | positive regulation of protein neddylation | 2.84e-07 | 5 | 64 | 3 | GO:2000436 | |
| GeneOntologyBiologicalProcess | regulation of protein neddylation | 3.13e-05 | 20 | 64 | 3 | GO:2000434 | |
| Domain | DCN-prot | 3.64e-07 | 5 | 63 | 3 | IPR014764 | |
| Domain | PONY_dom | 3.64e-07 | 5 | 63 | 3 | IPR005176 | |
| Domain | DCUN1 | 3.64e-07 | 5 | 63 | 3 | PS51229 | |
| Domain | Cullin_binding | 3.64e-07 | 5 | 63 | 3 | PF03556 | |
| Domain | Ryanrecept_TM4-6 | 3.35e-05 | 3 | 63 | 2 | IPR009460 | |
| Domain | RyR | 3.35e-05 | 3 | 63 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 3.35e-05 | 3 | 63 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 3.35e-05 | 3 | 63 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.35e-05 | 3 | 63 | 2 | IPR013333 | |
| Domain | EF_hand_dom | 1.30e-04 | 232 | 63 | 6 | IPR002048 | |
| Domain | RIH_assoc | 1.67e-04 | 6 | 63 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.67e-04 | 6 | 63 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.67e-04 | 6 | 63 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.67e-04 | 6 | 63 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.67e-04 | 6 | 63 | 2 | IPR015925 | |
| Domain | - | 1.67e-04 | 6 | 63 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.67e-04 | 6 | 63 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.67e-04 | 6 | 63 | 2 | PF08709 | |
| Domain | - | 2.45e-04 | 261 | 63 | 6 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 4.07e-04 | 287 | 63 | 6 | IPR011992 | |
| Domain | MIR | 4.95e-04 | 10 | 63 | 2 | PS50919 | |
| Domain | MIR | 4.95e-04 | 10 | 63 | 2 | PF02815 | |
| Domain | MIR | 4.95e-04 | 10 | 63 | 2 | SM00472 | |
| Domain | MIR_motif | 4.95e-04 | 10 | 63 | 2 | IPR016093 | |
| Domain | EF_HAND_2 | 1.09e-03 | 231 | 63 | 5 | PS50222 | |
| Domain | PI3/4_kinase_CS | 1.14e-03 | 15 | 63 | 2 | IPR018936 | |
| Domain | - | 1.30e-03 | 16 | 63 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.30e-03 | 16 | 63 | 2 | SM00146 | |
| Domain | UBA-like | 1.32e-03 | 64 | 63 | 3 | IPR009060 | |
| Domain | PI3/4_kinase_cat_dom | 1.65e-03 | 18 | 63 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.65e-03 | 18 | 63 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.65e-03 | 18 | 63 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.65e-03 | 18 | 63 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.65e-03 | 18 | 63 | 2 | PS00916 | |
| Domain | EFh | 1.99e-03 | 158 | 63 | 4 | SM00054 | |
| Domain | EF_Hand_1_Ca_BS | 2.89e-03 | 175 | 63 | 4 | IPR018247 | |
| Domain | EF-hand_5 | 3.20e-03 | 25 | 63 | 2 | PF13202 | |
| Domain | EF_HAND_1 | 4.98e-03 | 204 | 63 | 4 | PS00018 | |
| Domain | EF-hand_8 | 5.86e-03 | 34 | 63 | 2 | PF13833 | |
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 15988528 | ||
| Pubmed | The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. | 1.42e-06 | 12 | 66 | 3 | 19617556 | |
| Pubmed | 1.84e-06 | 13 | 66 | 3 | 23201271 | ||
| Pubmed | Curcumin Delays Retinal Degeneration by Regulating Microglia Activation in the Retina of rd1 Mice. | 3.55e-06 | 2 | 66 | 2 | 29145208 | |
| Pubmed | An intrinsic neural oscillator in the degenerating mouse retina. | 3.55e-06 | 2 | 66 | 2 | 21451038 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 3.55e-06 | 2 | 66 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 3.55e-06 | 2 | 66 | 2 | 26009179 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32899693 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 30542613 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 10739679 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 3.55e-06 | 2 | 66 | 2 | 11673493 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 11673462 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 3.55e-06 | 2 | 66 | 2 | 25370123 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 3.55e-06 | 2 | 66 | 2 | 15033925 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 3.55e-06 | 2 | 66 | 2 | 18618700 | |
| Pubmed | Characterization of the mammalian family of DCN-type NEDD8 E3 ligases. | 5.22e-06 | 18 | 66 | 3 | 26906416 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX2 UNC119 MAN2A2 LATS2 MYO9B SLC25A39 PI4KA PRKDC PLEC PPP2R3C RYR1 | 6.87e-06 | 1105 | 66 | 11 | 35748872 |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18403125 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18434746 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 21985934 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.06e-05 | 3 | 66 | 2 | 9204703 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 7876312 | ||
| Pubmed | Retinal degeneration increases susceptibility to myopia in mice. | 1.06e-05 | 3 | 66 | 2 | 24146540 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 21881589 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 24123915 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.06e-05 | 3 | 66 | 2 | 12213830 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 23278119 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 9242641 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 22948152 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 1.06e-05 | 3 | 66 | 2 | 23454728 | |
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.06e-05 | 3 | 66 | 2 | 10788707 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 7538211 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.06e-05 | 3 | 66 | 2 | 7621815 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 18643873 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 11159936 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 1.06e-05 | 3 | 66 | 2 | 9986730 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.06e-05 | 3 | 66 | 2 | 10473538 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.06e-05 | 3 | 66 | 2 | 4600883 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 7635066 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 18206662 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 22504960 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 4595403 | ||
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 2.12e-05 | 4 | 66 | 2 | 23992453 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.12e-05 | 4 | 66 | 2 | 23413940 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 9384575 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 25477496 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 9607712 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 27226555 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 19120137 | ||
| Pubmed | Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella. | 2.12e-05 | 4 | 66 | 2 | 32703879 | |
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 2.12e-05 | 4 | 66 | 2 | 11237759 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 23482488 | ||
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 3.53e-05 | 5 | 66 | 2 | 22939628 | |
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 3.53e-05 | 5 | 66 | 2 | 9124414 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.53e-05 | 5 | 66 | 2 | 19011160 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 10729222 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 5.29e-05 | 6 | 66 | 2 | 26025922 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 5.29e-05 | 6 | 66 | 2 | 14592808 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.29e-05 | 6 | 66 | 2 | 25966694 | |
| Pubmed | Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. | 5.29e-05 | 6 | 66 | 2 | 29153842 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 19009018 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 6980940 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.29e-05 | 6 | 66 | 2 | 16844763 | |
| Pubmed | Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. | 7.40e-05 | 7 | 66 | 2 | 24011591 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 11860456 | ||
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 20962236 | ||
| Pubmed | SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1). | 9.86e-05 | 8 | 66 | 2 | 25349211 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 9.86e-05 | 8 | 66 | 2 | 19033399 | |
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 2787378 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 11784029 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 9169155 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 18434328 | ||
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 1.58e-04 | 10 | 66 | 2 | 25605905 | |
| Pubmed | The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. | 1.93e-04 | 11 | 66 | 2 | 15147269 | |
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 28973896 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 9417917 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 19095005 | ||
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 35850054 | ||
| Pubmed | An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents. | 2.73e-04 | 13 | 66 | 2 | 32259485 | |
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 3.18e-04 | 14 | 66 | 2 | 28724790 | |
| Pubmed | 3.18e-04 | 14 | 66 | 2 | 18626009 | ||
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 31494268 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 18258596 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 38448588 | ||
| Pubmed | 4.18e-04 | 16 | 66 | 2 | 32730753 | ||
| Pubmed | Conserved and Divergent Features of Human and Mouse Kidney Organogenesis. | 4.74e-04 | 17 | 66 | 2 | 29449453 | |
| Pubmed | 4.74e-04 | 17 | 66 | 2 | 25327288 | ||
| Pubmed | 4.74e-04 | 17 | 66 | 2 | 21082674 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PCNX2 MALT1 PPP2R2C LATS2 ATG7 INPP5A PURA CAB39L GRIK1 CSMD1 | 4.76e-04 | 1489 | 66 | 10 | 28611215 |
| Pubmed | The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. | 5.19e-04 | 82 | 66 | 3 | 25260751 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 5.57e-04 | 84 | 66 | 3 | 25670202 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.01e-04 | 202 | 66 | 4 | 33005030 | |
| Cytoband | 4q21 | 3.80e-04 | 20 | 66 | 2 | 4q21 | |
| Cytoband | 22q11.21 | 5.63e-04 | 111 | 66 | 3 | 22q11.21 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.98e-05 | 3 | 47 | 2 | 287 | |
| GeneFamily | Neuropeptide receptors | 2.94e-04 | 10 | 47 | 2 | 854 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 6.80e-04 | 15 | 47 | 2 | 696 | |
| GeneFamily | EF-hand domain containing | 2.48e-03 | 219 | 47 | 4 | 863 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.64e-03 | 57 | 47 | 2 | 1179 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.16e-02 | 181 | 47 | 3 | 694 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 3.91e-06 | 166 | 66 | 6 | M39026 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN | 1.14e-05 | 200 | 66 | 6 | M6607 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 5.21e-07 | 200 | 66 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.21e-07 | 200 | 66 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 175 | 66 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.34e-06 | 186 | 66 | 5 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| Drug | AC1L380G | 2.08e-05 | 19 | 65 | 3 | CID000084698 | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 3546_UP | |
| Drug | 2-hydroxycarbazole | 2.40e-05 | 3 | 65 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 2.40e-05 | 3 | 65 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.40e-05 | 3 | 65 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.40e-05 | 3 | 65 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.40e-05 | 3 | 65 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.40e-05 | 3 | 65 | 2 | CID009570289 | |
| Drug | PCB74 | 4.80e-05 | 4 | 65 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 4.80e-05 | 4 | 65 | 2 | CID006444275 | |
| Drug | SC 38249 | 4.80e-05 | 4 | 65 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 4.80e-05 | 4 | 65 | 2 | CID000035682 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.30e-05 | 3 | 62 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.30e-05 | 3 | 62 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (biomarker_via_orthology) | 6.48e-05 | 6 | 62 | 2 | DOID:1289 (biomarker_via_orthology) | |
| Disease | Combined immunodeficiency | 8.90e-05 | 41 | 62 | 3 | C0494261 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.50e-04 | 145 | 62 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 3.89e-04 | 14 | 62 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Amphetamine-Related Disorders | 5.36e-04 | 75 | 62 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 5.36e-04 | 75 | 62 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 5.36e-04 | 75 | 62 | 3 | C0236804 | |
| Disease | Lung diseases | 6.01e-04 | 78 | 62 | 3 | C0024115 | |
| Disease | lung cancer | 8.89e-04 | 21 | 62 | 2 | MONDO_0008903 | |
| Disease | coronary artery disease (is_implicated_in) | 1.24e-03 | 100 | 62 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | TEMPS-A questionnaire | 1.26e-03 | 25 | 62 | 2 | EFO_0004783 | |
| Disease | congestive heart failure (is_implicated_in) | 1.47e-03 | 27 | 62 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 1.70e-03 | 29 | 62 | 2 | OBA_2045183 | |
| Disease | immature platelet fraction | 1.80e-03 | 114 | 62 | 3 | EFO_0009187 | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 1.82e-03 | 30 | 62 | 2 | OBA_2045180 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.84e-03 | 115 | 62 | 3 | EFO_0007878, EFO_0010724 | |
| Disease | immature platelet measurement | 2.03e-03 | 119 | 62 | 3 | EFO_0803541 | |
| Disease | level of Sphingomyelin (d40:1) in blood serum | 2.07e-03 | 32 | 62 | 2 | OBA_2045182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSNQFRDFFKYVELS | 161 | Q9H9S4 | |
| GAYNNFFRMFDRNTK | 356 | Q9Y2T4 | |
| FVVFGQFAYFQTALN | 1661 | Q96PZ7 | |
| FASVFEKYFQFQEEG | 121 | O15144 | |
| SRKNNDIEQAFCFFY | 861 | P39086 | |
| YVFVGRDFQEKFFQS | 316 | O75388 | |
| RQTFQRFDKFNDKYN | 366 | P23109 | |
| LDYAQSRFQFYFQQK | 371 | Q9Y259 | |
| YFKFFTTGENARIFQ | 116 | Q9BXT2 | |
| PGRFKDFYQFTFNFA | 151 | Q96GG9 | |
| EDKFKDLYRFTFQFG | 176 | Q8IWE4 | |
| FFKFQFRNVEYSSGR | 51 | Q9Y235 | |
| QSYFKSQPFDFRGAQ | 161 | O75355 | |
| GFFNENFRRGFQEAF | 436 | Q9Y5X5 | |
| CEKFLQEVDFFQRYF | 751 | Q96HW7 | |
| ENKGYLNVFSLNYFF | 356 | Q969Q6 | |
| DSNVKFFYLNGNFSF | 441 | Q6IE37 | |
| EEHKFRNFFNAFYSV | 91 | Q96DC9 | |
| GFYVCRVNNNFTFEF | 186 | Q9UDY8 | |
| AFYEFTFRRFFDDNG | 1036 | Q9NRM7 | |
| SVGRAFQQFYKQFVE | 686 | Q9UQF2 | |
| KRFLDQLVGFFNFYN | 106 | Q9NQG7 | |
| DFYQFTFTFAKNPGQ | 156 | Q6PH85 | |
| QGKFNREQFYKFIIF | 801 | A6NKB5 | |
| RFEKVSYFVFGDFNF | 221 | Q14642 | |
| FDYFNQEVFRDNNGT | 286 | Q14642 | |
| FLDQNPDFARQYFGK | 11 | P35913 | |
| EQLSYLKGDNFFRFT | 91 | Q9H8E8 | |
| YNTFDTNKDGFVDFL | 61 | O95843 | |
| IYFNSFLQSFQGFFV | 341 | Q13324 | |
| PAKDFYQREFDFFNK | 1726 | P42356 | |
| DFYQREFDFFNKITN | 196 | Q8N8J0 | |
| YKFKFQRIFDQDANQ | 56 | Q6ZMV9 | |
| EYFGNFAFDKNSINI | 446 | Q9NVV4 | |
| GFLNKNFQRDLQFFF | 321 | P25929 | |
| KDFSFRFLFGIYQQA | 236 | P11117 | |
| EFGNYLFRQNRFYDA | 176 | O75344 | |
| QAFGFDQTFQSYRKD | 46 | Q9BRQ4 | |
| NFYSNEQITDFGFKF | 3016 | O60494 | |
| FYFQNDVKANTYFLE | 2866 | Q4G0P3 | |
| QYEREGFNFLAKVFN | 656 | O95352 | |
| VDFEDNYQFAKYRSF | 196 | Q15485 | |
| FVLDYFFEEKQNLRF | 71 | Q8IYJ1 | |
| YTFQVKINNDFNYEF | 186 | P10643 | |
| DAQFFNYQRLFDFFN | 436 | P49641 | |
| AFNFFRKFYNKSEDE | 4856 | P21817 | |
| FNFFRKFYNKSEDGD | 4786 | Q92736 | |
| EIYNLSANYFQEKFF | 41 | Q969X6 | |
| KQEEAFRSYFEIFNG | 221 | Q7Z572 | |
| NEGVSYEFKFPFRNN | 1051 | O43166 | |
| RGFFNYQASIFAENF | 356 | Q13621 | |
| DFYQRGFDFFNKITN | 196 | A4QPH2 | |
| RNLFAFFDMAYQGFA | 236 | P00505 | |
| YFRNQLLKSFDFHFG | 166 | Q13432 | |
| TDGFFIFNERFKNFT | 376 | O60858 | |
| YEFGKSFFQRLNQDR | 341 | Q9BZJ4 | |
| RLAKYFFNKEGDFNN | 276 | Q15269 | |
| EYLDRNNKFNFQGYS | 451 | Q8IWV7 | |
| KENAAYFQFFSDVRE | 856 | Q15149 | |
| YFQFFSDVREAEGQL | 861 | Q15149 | |
| FYFRNDSEYRQFEGL | 116 | O75290 | |
| FFNIFTRQCEEFIYG | 71 | P10646 | |
| FEYFSETQRNKGNFP | 66 | A0A578 | |
| FNELKFYQGFLFSEK | 1956 | P78527 | |
| ERLLFNFSKDNNFDY | 536 | Q9Y6R1 | |
| NFSKDNNFDYLEFRL | 541 | Q9Y6R1 | |
| VDNKRFFFDVGSNKY | 226 | Q00577 | |
| FQYNKYVKIFDNFSN | 216 | O14628 | |
| DFERNSFEQFCINYA | 526 | Q13459 | |
| NDDGKLSFEEFQNYF | 51 | Q96P71 |